UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000040099
Receipt number R000045720
Scientific Title Diagnostic quality of Endoscopic Ultrasound-guided Fine Needle Aspiration for Onco-panel for Geneprofiling of pancreatic cancer - Prospective cohort study -
Date of disclosure of the study information 2020/04/10
Last modified on 2020/04/07 20:37:46

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Diagnostic quality of Endoscopic Ultrasound-guided Fine Needle Aspiration for Onco-panel for Geneprofiling of pancreatic cancer - Prospective cohort study -

Acronym

EUS-FNA for Onco-panel for Geneprofiling

Scientific Title

Diagnostic quality of Endoscopic Ultrasound-guided Fine Needle Aspiration for Onco-panel for Geneprofiling of pancreatic cancer - Prospective cohort study -

Scientific Title:Acronym

EUS-FNA for Onco-panel for Geneprofiling

Region

Japan


Condition

Condition

pancreatic cancer

Classification by specialty

Hepato-biliary-pancreatic medicine

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

To clarify how Onco-panel for Geneprofiling can be evaluated by specimens of EUS-FNA for pancreatic cancer.

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Diagnostic sensitivity of Onco-panel for Geneprofiling by specimens of EUS-FNA for pancreatic cancer

Key secondary outcomes



Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

Patients with unresectable pancreatic cancer diagnosed by imaging and clinically judged to be eligible for Onco-panel for Geneprofiling during the course of chemotherapy

Key exclusion criteria

# Patients who have tendency of bleeding
# The lesion cannot be demonstrated
# Patients who have the high risk of complication by EUS-FNA
# There are some definite vessels between EUS and lesions
# The movement by breathing may cause puncture of another organs
# Patients who don't understand the aim of this study

Target sample size

30


Research contact person

Name of lead principal investigator

1st name Ichiro
Middle name
Last name Yasuda

Organization

University of Toyama

Division name

Third Department of Internal Medicine

Zip code

930-0194

Address

2630 Sugitani, Toyama city, Toyama prefecture, Japan

TEL

076-434-7301

Email

yasudaich@gmail.com


Public contact

Name of contact person

1st name Kosuke
Middle name
Last name Takahashi

Organization

University of Toyama

Division name

Third Department of Internal Medicine

Zip code

930-0194

Address

2630 Sugitani, Toyama city, Toyama prefecture, Japan

TEL

076-434-7301

Homepage URL


Email

takapochi0809@gmail.com


Sponsor or person

Institute

University of Toyama

Institute

Department

Personal name



Funding Source

Organization

None

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Center for Clinical Reserch in Toyama University Hospital

Address

2630 Sugitani, Toyama city, Toyama prefecture, Japan

Tel

076-415-8857

Email

rinri@adm.u-toyama.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2020 Year 04 Month 10 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Open public recruiting

Date of protocol fixation

2020 Year 01 Month 24 Day

Date of IRB

2020 Year 03 Month 18 Day

Anticipated trial start date

2020 Year 04 Month 06 Day

Last follow-up date

2021 Year 09 Month 30 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

We evaluate diagnostic sensitivity of Onco-panel for Geneprofiling by EUS-FNA for pancreatic cancer.


Management information

Registered date

2020 Year 04 Month 07 Day

Last modified on

2020 Year 04 Month 07 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000045720


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name